查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1529823

精神科數位生物標記市場規模、佔有率和趨勢分析報告：按類型、醫療實踐、最終用途、地區和細分趨勢：2024-2030

Psychiatric Digital Biomarkers Market Size, Share & Trends Analysis Report By Type, By Clinical Practice, By End Use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

精神科數位生物標記市場趨勢

預計 2023 年全球精神科數位生物標記市場規模為 5.219 億美元，2024 年至 2030 年複合年成長率預估為 23.9%。精神疾病盛行率的增加、數位健康技術的進步以及對個人化醫療的需求不斷成長正在推動市場發展。穿戴式裝置和行動醫療應用程式在精神健康保健領域的日益普及也促進了市場的成長。 2024 年 4 月，Sensors 發表了一篇關於數位表現型分析對神經系統疾病影響的綜述，展示了透過遠端醫療和感測器技術改善臨床試驗並支持早期檢測和監測的潛力。

憂鬱症、焦慮症、躁鬱症和思覺失調症等精神疾病影響全世界數百萬人。根據美國心理健康公司的數據，2023 年，12 至 17 歲的青少年中有 20.17% 經歷過嚴重憂鬱症，15% 患有嚴重殘疾，影響了他們的日常生活。這種日益增加的盛行率促使需要更有效的工具來監測和管理心理健康狀況，導致人們對精神病數位生物標記物的興趣增加。 2022 年 7 月，普適和行動運算發表的研究表明，憂鬱症患者和非憂鬱症患者的情緒和數字標記（例如睡眠和電話使用）存在顯著差異。也證實，這些數位生物標記物單獨或與情緒評估相結合，可以準確預測憂鬱症狀態。

數位健康科技的進步將徹底改變心理健康領域。人工智慧 (AI)、機器學習和資料分析等技術創新促進了先進數位生物標記的開發，為個人心理健康狀況提供了寶貴的見解。人工智慧驅動的演算法分析來自智慧型手機感測器的資料，以檢測行為模式的變化，這些變化表明心理健康危機的早期徵兆。

2023 年 11 月，《精神病學前沿》上的報導強調了數位生物標記在預測和管理情緒障礙方面的潛力、智慧型手機資料如何監測憂鬱症和治療反應，以及穿戴式裝置如何監測現實世界中的憂鬱症和治療反應。

隨著醫療保健提供者尋求根據患者個別需求量身定做治療計劃，精神健康保健中對個人化醫療的需求不斷成長。精神科數位生物標記透過提供有關患者症狀和治療反應的客觀資料，在實現個人化介入方面發揮重要作用。穿戴式裝置和行動醫療應用程式的日益普及將透過在傳統臨床環境之外實現持續的患者監測來進一步加速這一趨勢。 2022 年 3 月，DTU 健康科技的研究人員開發了一種使用語音分析來識別個別雙相情感障礙並監測患者情緒變化的方法，發現個人化模型提供的結果是最準確的。

全球精神科數位生物標記市場報告細分

該報告預測了全球、區域和國家層面的收益成長，並對 2018 年至 2030 年各子區隔的最新行業趨勢進行了分析。在這項研究中，Grand View Research, Inc. 根據類型、臨床實踐、最終用途和地區對全球精神科數位生物標記市場報告進行了細分。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第 3 章 精神科數位生物標記市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/補充市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 精神科數位生物標記市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第 4 章 精神科數位生物標記市場：按類型估計和趨勢分析

  • 細分儀表板
  • 全球精神科數位生物標記市場類型變化分析
  • 2018-2030 年全球精神科數位生物標記市場規模與趨勢分析（按類型）
  • 穿戴式的
  • 基於行動的應用程式
  • 感應器
  • 其他

第5章精神科數位生物標記市場：臨床實踐的估計和趨勢分析

  • 細分儀表板
  • 全球精神科數位生物標記市場的臨床實踐變化分析
  • 2018-2030 年全球精神科數位生物標記市場規模與趨勢分析（按臨床實務）
  • 精神科數位生物標記診斷
  • 精神科數位生物標記監測
  • 使用數位生物標記預測和預後精神障礙
  • 其他（安全性、動態/反應、敏感性）

第6章 精神科數位生物標記市場：最終用途的估計與趨勢分析

  • 細分儀表板
  • 全球精神科數位生物標記市場的最終用途變化分析
  • 2018-2030 年全球精神科數位生物標記市場規模與趨勢分析（依最終用途）
  • 醫療公司
  • 醫療提供者
  • 付款人
  • 其他（病人、看護者）

第 7 章 精神科數位生物標記市場：區域、估計與趨勢分析

  • 2023 年及 2030 年按地區分類的市場佔有率分析
  • 區域市場儀表板
  • 2018-2030年市場規模、預測趨勢分析
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 公司/競爭對手分類
  • 策略規劃
  • 2023 年企業市場分析
  • 公司簡介/上市公司
    • Koneksa
    • Biogen Inc.
    • Empatica Inc.
    • Vivo Sense
    • IXICO plc
    • Huma
    • Sonde Health, Inc.
    • Clario
Product Code: GVR-4-68040-367-6

Psychiatric Digital Biomarkers Market Trends

The global psychiatric digital biomarkers market was estimated at USD 521.9 million in 2023 and is projected to grow at a CAGR of 23.9% from 2024 to 2030. The increasing prevalence of mental health disorders, advancements in digital health technologies and growing demand for personalized medicine drive the market. Rising adoption of wearable devices and mobile health apps in mental healthcare contribute to the market growth. In April 2024, Sensors published a review on digital phenotyping's impact on neurological diseases, showing its potential to refine clinical trials and aid in early detection and monitoring through telemedicine and sensor technologies.

The global burden of mental health disorders is on the rise, with conditions such as depression, anxiety, bipolar disorder, and schizophrenia affecting millions of people worldwide. In 2023, Mental Health America, Inc. found that 20.17% of youths aged 12-17 had encountered a major depressive episode, with 15% suffering severe impairment affecting daily activities. This increasing prevalence is driving the need for more effective tools to monitor and manage mental health conditions, leading to a growing interest in psychiatric digital biomarkers. In July 2022, Pervasive and Mobile Computing published findings showing significant differences in mood and digital markers (such as sleep and phone usage) between depressed and non-depressed individuals. It also confirmed that depression status could be accurately predicted using these digital biomarkers alone or combined with mood ratings.

Technological advancements in digital health technologies revolutionize the field of mental healthcare. Innovations such as artificial intelligence (AI), machine learning, and data analytics enable the development of sophisticated digital biomarkers that provide valuable insights into an individual's mental health status. AI-powered algorithms analyze data from smartphone sensors to detect changes in behavior patterns that indicate early signs of a mental health crisis.

In November 2023, an article in Frontiers in Psychiatry highlighted the potential of digital biomarkers in predicting and managing mood disorders, noting how smartphone data can monitor depression and treatment responses, wearable devices can track mood disorders more accurately in real-world settings, and AI advancements are opening up new diagnostic and therapeutic avenues.

There is a growing demand for personalized medicine in mental healthcare, as healthcare providers seek to tailor treatment plans to individual patients' needs. Psychiatric digital biomarkers play a crucial role in enabling personalized interventions by providing objective data on patients' symptoms and treatment responses. The increasing adoption of wearable devices and mobile health apps further fuels this trend, allowing for continuous monitoring of patients outside traditional clinical settings. In March 2022, DTU Health Tech researchers developed a method using voice analysis to identify bipolar disorder in individuals and monitor mood changes in patients, with personalized models providing the most accurate results.

Global Psychiatric Digital Biomarkers Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global psychiatric digital biomarkers market report based on type, clinical practice, end use, and region.

  • Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Wearable
  • Mobile based Applications
  • Sensors
  • Others
  • Clinical Practice Outlook (Revenue, USD Million, 2018 - 2030)
  • Diagnostic Psychiatric Digital Biomarkers
  • Monitoring Psychiatric Digital Biomarkers
  • Predictive and Prognostic Psychiatric Digital Biomarkers
  • Other's (Safety, Pharmacodynamics/ Response, Susceptibility)
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Healthcare companies
  • Healthcare Providers
  • Payers
  • Others (Patient, caregivers)
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America

U.S.

Canada

Mexico

  • Europe

Germany

UK

France

Italy

Spain

Denmark

Sweden

Norway

  • Asia Pacific

China

Japan

India

South Korea

Australia

Thailand

  • Latin America

Brazil

Argentina

  • MEA

South Africa

Saudi Arabia

UAE

Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Type
    • 1.2.2. Clinical Practice
    • 1.2.3. End Use
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Psychiatric Digital Biomarkers Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of mental health disorders,
      • 3.2.1.2. Advancements in digital health technologies
      • 3.2.1.3. Growing demand for personalized medicine
      • 3.2.1.4. Rising adoption of wearable devices and mobile health apps
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Regulatory hurdles
  • 3.3. Psychiatric Digital Biomarkers Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces
    • 3.3.2. PESTEL Analysis

Chapter 4. Psychiatric Digital Biomarkers Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Psychiatric Digital Biomarkers Market Type Movement Analysis
  • 4.3. Global Psychiatric Digital Biomarkers Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Wearable
    • 4.4.1. Wearable market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Mobile based Applications
    • 4.5.1. Mobile based applications market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Sensors
    • 4.6.1. Sensors market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Others
    • 4.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Psychiatric Digital Biomarkers Market: Clinical Practice Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Psychiatric Digital Biomarkers Market Clinical Practice Movement Analysis
  • 5.3. Global Psychiatric Digital Biomarkers Market Size & Trend Analysis, by Clinical Practice, 2018 to 2030 (USD Million)
  • 5.4. Diagnostic Psychiatric Digital Biomarkers
    • 5.4.1. Diagnostic psychiatric digital biomarkers market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Monitoring Psychiatric Digital Biomarkers
    • 5.5.1. Monitoring psychiatric digital biomarkers market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Predictive and Prognostic Psychiatric Digital Biomarkers
    • 5.6.1. Predictive and prognostic psychiatric digital biomarkers market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Other's (Safety, Pharmacodynamics/ Response, Susceptibility)
    • 5.7.1. Other's (safety, pharmacodynamics/ response, susceptibility) market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Psychiatric Digital Biomarkers Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Psychiatric Digital Biomarkers Market End Use Movement Analysis
  • 6.3. Global Psychiatric Digital Biomarkers Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Healthcare Companies
    • 6.4.1. Healthcare companies market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Healthcare Providers
    • 6.5.1. Healthcare providers market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Payers
    • 6.6.1. Payers market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Others (Patient, Caregivers)
    • 6.7.1. Others (patient, caregivers) market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Psychiatric Digital Biomarkers Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. U.S.
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Canada
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. Mexico
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. UK
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. Germany
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. France
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Italy
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. Spain
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Norway
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.7. Sweden
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Regulatory framework
      • 7.5.7.3. Competitive scenario
      • 7.5.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Regulatory framework
      • 7.5.8.3. Competitive scenario
      • 7.5.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Japan
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. China
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. India
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. Australia
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.6. Thailand
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Brazil
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Argentina
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. South Africa
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.2. Saudi Arabia
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.3. UAE
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Regulatory framework
      • 7.8.3.3. Competitive scenario
      • 7.8.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.4. Kuwait
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Regulatory framework
      • 7.8.4.3. Competitive scenario
      • 7.8.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2023
  • 8.4. Company Profiles/Listing
    • 8.4.1. Koneksa
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Type benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Biogen Inc.
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Type benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Empatica Inc.
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Type benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Vivo Sense
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Type benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. IXICO plc
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Type benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Huma
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Type benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Sonde Health, Inc.
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Type benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Clario
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Type benchmarking
      • 8.4.8.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global psychiatric digital biomarkers market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 4 Global psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 5 Global psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
  • Table 6 North America psychiatric digital biomarkers market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 8 North America psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 9 North America psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
  • Table 10 U.S. psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 11 U.S. psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 12 U.S. psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
  • Table 13 Canada psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 14 Canada psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 15 Canada psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 Mexico psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 17 Mexico psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 18 Mexico psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 Europe psychiatric digital biomarkers market, by country, 2018 - 2030 (USD Million)
  • Table 20 Europe psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 21 Europe psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 22 Europe psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
  • Table 23 Germany psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 24 Germany psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 25 Germany psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
  • Table 26 UK psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 27 UK psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 28 UK psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 France psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 30 France psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 31 France psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
  • Table 32 Italy psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 33 Italy psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 34 Italy psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
  • Table 35 Spain psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 36 Spain psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 37 Spain psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
  • Table 38 Denmark psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 39 Denmark psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 40 Denmark psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 Sweden psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 42 Sweden psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million
  • Table 43 Sweden psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million
  • Table 44 Norway psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 45 Norway psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million
  • Table 46 Norway psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million
  • Table 47 Asia Pacific psychiatric digital biomarkers market, by country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million
  • Table 50 Asia Pacific psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million
  • Table 51 China psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 52 China psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 53 China psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
  • Table 54 Japan psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 55 Japan psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 56 Japan psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 India psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 58 India psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 59 India psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
  • Table 60 South Korea psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 61 South Korea psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 62 South Korea psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
  • Table 63 Australia psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 64 Australia psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 65 Australia psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
  • Table 66 Thailand psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 67 Thailand psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 68 Thailand psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
  • Table 69 Latin America psychiatric digital biomarkers market, by country, 2018 - 2030 (USD Million)
  • Table 70 Latin America psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 71 Latin America psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 72 Latin America psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
  • Table 73 Brazil psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 74 Brazil psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 75 Brazil psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
  • Table 76 Argentina psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 77 Argentina psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 78 Argentina psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
  • Table 79 MEA psychiatric digital biomarkers market, by country, 2018 - 2030 (USD Million)
  • Table 80 MEA psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 81 MEA psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 82 MEA psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
  • Table 83 South Africa psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 84 South Africa psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 85 South Africa psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
  • Table 89 UAE psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 90 UAE psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 91 UAE psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
  • Table 92 Kuwait psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 93 Kuwait psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 94 Kuwait psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 Psychiatric digital biomarkers market: Market outlook
  • Fig. 5 Psychiatric digital biomarkers market: Segment outlook
  • Fig. 6 Psychiatric digital biomarkers market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 Psychiatric digital biomarkers market driver impact
  • Fig. 9 Psychiatric digital biomarkers market restraint impact
  • Fig. 10 Psychiatric digital biomarkers market: Type outlook and key takeaways
  • Fig. 11 Psychiatric digital biomarkers market: Type movement analysis
  • Fig. 12 Wearable market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 13 Mobile based applications market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 14 Sensors market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 16 Psychiatric digital biomarkers market: Clinical Practice outlook and key takeaways
  • Fig. 17 Psychiatric digital biomarkers market: Clinical Practice movement analysis
  • Fig. 18 Diagnostic psychiatric digital biomarkers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Monitoring psychiatric digital biomarkers market estimates and forecast, 2018 - 2030 (USD Million
  • Fig. 20 Predictive and prognostic psychiatric digital biomarkers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Other's (safety, pharmacodynamics/ response, susceptibility) market estimates and forecast, 2018 - 2030 (USD Million
  • Fig. 22 Psychiatric digital biomarkers market: End Use outlook and key takeaways
  • Fig. 23 Psychiatric digital biomarkers market: End Use movement analysis
  • Fig. 24 Healthcare companies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Healthcare providers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Payers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Global psychiatric digital biomarkers market: Regional outlook and key takeaways
  • Fig. 29 Global psychiatric digital biomarkers market: Regional movement analysis
  • Fig. 30 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)